Navigation Links
Hospira Announces Executive Changes
Date:3/1/2013

the company's spin-off from Abbott Laboratories, Mr. Bedward served as Abbott's senior counsel, litigation, where his practice included patent issues related to the Hatch-Waxman Act, defense of investigations, major commercial disputes, product liability matters and arbitrations.

Mr. Bedward began his career as an attorney for the law firm Jenner & Block, where he was ultimately promoted to partner. At the firm, he handled a wide array of complex litigation matters, including fraud and business torts, intellectual property matters, product liability and insurance recovery actions.

Born in Madison, Wis., Mr. Bedward earned his bachelor's degree in business administration, magna cum laude, from Saint Norbert College.  He holds a juris doctorate degree, magna cum laude, from the University of Illinois College of Law, where he also served as an editor on the Law Review.

In another organizational move, Hospira announced that Sumant Ramachandra, M.D., Ph.D., is resigning from his position as senior vice president and chief scientific officer, effective March 8. Dr. Ramachandra has served in this role since 2008. The company has initiated a search for his successor and instituted an interim reporting structure that will ensure seamless advancement of the company's research and development priorities, including its global expansion and biosimilars programs.

Said Mr. Ball, "On behalf of Hospira, I'd like to thank Sumant for his many contributions and wish him the best in his future endeavors. During his tenure, we have established one of the most robust biosimilars pipelines in the industry, expanded an already market-leading generic injectables portfolio and built a talented scientific, medical and regulatory organization to execute our vision for future success."

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Reports First-Quarter 2012 Results
3. Hospira to Present at Upcoming Investor Conferences
4. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
5. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
6. Hospira to Host Conference Call for Second-quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira Reports Second-Quarter 2012 Results
9. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
10. Hospira Reports Third-Quarter 2012 Results
11. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... Sequent Medical, Inc. announced today that it ... family of WEB ® Aneurysm Embolization Devices, and ... in select neurovascular centers in Europe.  The SL family ... enable physicians to treat a broader range of aneurysms ... are made possible by further advancement of Sequent Medical,s ...
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Caremark announced today that it has donated approximately $40,000 ... Joplin, MO, including some of the company,s pharmacy benefit ... by the recent tornado. CVS Caremark and CVS/pharmacy colleagues ... personal care supplies valued at approximately $35,000 to local ...
... Perma-Fix Environmental Services, Inc. (NASDAQ: PESI ... agreement with Battelle, which operates Pacific Northwest National Laboratory ... from PNNL for use with Perma-Fix,s proprietary process to ... to make Technetium 99m (Tc-99m).Tc-99m is the most widely ...
Cached Medicine Technology:CVS Caremark and Area Colleagues Provide $40,000 of Support to Tornado Relief Efforts in Joplin, MO 2Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes 2Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes 3Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes 4
(Date:5/20/2013)... San Diego, CA (PRWEB) May 20, 2013 ... country and around the world will make the pilgrimage ... for the 2nd annual Digital Health Summer Summit ... two-day conference provides a unique forum to showcase the ... lessons and best practices, and network with some of ...
(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 ... of innovative cloud and on-premise business process ... version 6.0 of its next-generation integration solution. ... data integration solution that seamlessly automates business ... and reporting with meaningful business user interaction ...
(Date:5/20/2013)... 20 (HealthDay News) -- Although many hospital intensive ... staff to help improve outcomes, new research suggests ... Since one-third of teaching hospitals in the ... staff a nighttime physician in the ICU, the ... doctors away from hospitals with fewer resources, the ...
(Date:5/20/2013)... 20, 2013 In celebration of National ... scientific accomplishments achieved at The Feinstein Institute for ... scientists, Advancing Women in Science and Medicine (AWSM) ... 17. Scientists, educators, business and community leaders from ... achievements of women in science. , “Women face ...
(Date:5/20/2013)... about toothpaste that transforms the sweet flavor of orange ... that mysterious sensory phenomenon in colorful, animated detail ... Society,s award-winning Bytesize Science video series at ... largest scientific society, explains that the mainstay ingredients in ... SLS for short. When you brush your teeth, SLS ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... HOUSTON Regardless of an individual,s dietary and lifestyle ... deprived neighborhood may increase a person,s risk for death, ... Cancer Research Conference on Frontiers in Cancer Prevention Research, ... Diet and Health Study and found that people living ...
... M.D., Professor of Medicine at Case Western Reserve University ... Medical Center has been awarded a 10 year, $19.7M ... Prevention (CDC) as an international clinical trials site for ... is a partnership of U.S. and international clinical investigators ...
... , NEW YORK, Dec. ... report is available in its catalogue: , ... http://www.reportlinker.com/p0167257/Mesenchymal-Stem-Cells-Advances--Applications.html , Mesenchymal stem cells (MSCs) are ... of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic ...
... , , Through her ... of urological patient care , BALTIMORE, Dec. 8 ... its Executive Director Sandra Vassos was presented with the Star ... Star Breakfast in New York City. The Star Award recognizes ...
... ... to hip replacement surgery in patients 20 – 60 years of age. , ... (PRWEB) December 8, 2009 -- Dr. Einhorn’s ... offers patients a less invasive alternative to hip replacement., , ,Using non-embryonic stem cells harvested ...
... , CHARLOTTE, N.C., Dec. ... the Blue Cross and Blue Shield Association (BCBSA) as ... EPLS and USA PATRIOT Act compliance solutions. Under the contract, ... its member Blue Cross and Blue Shield companies nationwide. ...
Cached Medicine News:Health News:People living in poorer neighborhoods at increased risk for death, worse health risks 2Health News:Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 2Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 3Health News:Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications 4Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 2Health News:The National Blue Cross and Blue Shield Association Selects ATTUS Technologies as Preferred Provider for OFAC, OIG, EPLS and USA PATRIOT Act Compliance 3
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
... Arthroscopy Scissor is ideal for excising soft tissue ... in the joint. The serrated edge on the ... as hold tissue within the jaws for more ... right jaw curvatures, are the perfect tools for ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
Medicine Products: